Cargando…

Drug–Drug Interactions of Infectious Disease Treatments in Low‐Income Countries: A Neglected Topic?

Despite recent advances in recognizing and reducing the risk of drug–drug interactions (DDIs) in developed countries, there are still significant challenges in managing DDIs in low‐income countries (LICs) worldwide. In the treatment of major infectious diseases in these regions, multiple factors con...

Descripción completa

Detalles Bibliográficos
Autores principales:	McFeely, Savannah J., Yu, Jingjing, Zhao, Ping, Hershenson, Susan, Kern, Steven, Ragueneau‐Majlessi, Isabelle, Hartman, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563420/ https://www.ncbi.nlm.nih.gov/pubmed/30771252 http://dx.doi.org/10.1002/cpt.1397

Ejemplares similares

Variability in In Vitro OATP1B1/1B3 Inhibition Data: Impact of Incubation Conditions on Variability and Subsequent Drug Interaction Predictions
por: McFeely, Savannah J., et al.
Publicado: (2019)

Excipient knowledgebase: Development of a comprehensive tool for understanding the disposition and interaction potential of common excipients
por: McFeely, Savannah J., et al.
Publicado: (2021)

Identification and Evaluation of Clinical Substrates of Organic Anion Transporting Polypeptides 1B1 and 1B3
por: McFeely, Savannah J., et al.
Publicado: (2019)

In Vitro‐to‐In Vivo Extrapolation of Transporter Inhibition Data for Drugs Approved by the US Food and Drug Administration in 2018
por: Yu, Jingjing, et al.
Publicado: (2020)

A useful tool for drug interaction evaluation: The University of Washington Metabolism and Transport Drug Interaction Database
por: Hachad, Houda, et al.
Publicado: (2010)

e-PKGene: A knowledge-based research tool for analysing the impact of genetics on drug exposure
por: Hachad, Houda, et al.
Publicado: (2011)

Seeing what is behind the smokescreen: A systematic review of methodological aspects of smoking interaction studies over the last three decades and implications for future clinical trials
por: Hermann, Robert, et al.
Publicado: (2023)

Expansion of the genetic code through reassignment of redundant sense codons using fully modified tRNA
por: McFeely, Clinton A L, et al.
Publicado: (2022)

Organ Impairment—Drug–Drug Interaction Database: A Tool for Evaluating the Impact of Renal or Hepatic Impairment and Pharmacologic Inhibition on the Systemic Exposure of Drugs
por: Yeung, CK, et al.
Publicado: (2015)

Model‐Informed Assessment of Anti‐Infectives for Young Children in Low‐ and Middle‐Income Countries
por: Zhao, Ping, et al.
Publicado: (2019)

Bespoke Drug Discovery Training for Low-Middle Income Countries
por: Webster, Lauren A., et al.
Publicado: (2023)

Predicting substrates of the human breast cancer resistance protein using a support vector machine method
por: Hazai, Eszter, et al.
Publicado: (2013)

Extensive breaking of genetic code degeneracy with non-canonical amino acids
por: McFeely, Clinton A. L., et al.
Publicado: (2023)

Wellness in residency: Addressing the neglected need in lower middle-income countries
por: Khalil, Muhammad Tawab, et al.
Publicado: (2023)

Controlling infectious disease outbreaks in low-income and middle-income countries
por: Caeiro, Juan Pablo, et al.
Publicado: (2018)

Correction to “Bespoke Drug Discovery Training for Low-Middle Income Countries”
por: Webster, Lauren A., et al.
Publicado: (2023)

Development and application of a PBPK modeling strategy to support antimalarial drug development
por: Abla, Nada, et al.
Publicado: (2023)

Estimation of brain receptor occupancy for trazodone immediate release and once a day formulations
por: Oggianu, Laura, et al.
Publicado: (2022)

Neglected infectious diseases: Are push and pull incentive mechanisms suitable for promoting drug development research?
por: Mueller-Langer, Frank
Publicado: (2013)

Narratives of veterinary drug use in northern Tanzania and consequences for drug stewardship strategies in low-income and middle-income countries
por: Caudell, Mark, et al.
Publicado: (2022)

Comment on “The impact of the COVID-19 pandemic on the presentation status of newly diagnosed melanoma: A single institution experience”
por: McFeely, Orla, et al.
Publicado: (2021)

Registering New Drugs for Low-Income Countries: The African Challenge
por: Moran, Mary, et al.
Publicado: (2011)

Children with Developmental Disabilities in Low- and Middle-Income Countries: More Neglected and Physically Punished
por: Bizzego, Andrea, et al.
Publicado: (2020)

Changing food systems and infectious disease risks in low-income and middle-income countries
por: Waage, Jeff, et al.
Publicado: (2022)

Innovations in Pediatric Drug Formulations and Administration Technologies for Low Resource Settings
por: Gerrard, Stephen E., et al.
Publicado: (2019)

Gender equity in mass drug administration for neglected tropical diseases: data from 16 countries
por: Cohn, Daniel A, et al.
Publicado: (2019)

Technologies for Detecting Falsified and Substandard Drugs in Low and Middle-Income Countries
por: Kovacs, Stephanie, et al.
Publicado: (2014)

The impact of “male clinics” on health-seeking behaviors of adult men in rural Kenya
por: Dowden, Justine, et al.
Publicado: (2019)

Pregnancy exposure registries for drugs and vaccines in low-income and middle-income countries: scoping review protocol
por: AbuShweimeh, Rahmeh, et al.
Publicado: (2023)

Advances in Emerging and Neglected Infectious Diseases
por: Spencer, Charles T., et al.
Publicado: (2017)

Evaluations of training and education interventions for improved infectious disease management in low-income and middle-income countries: a systematic literature review
por: van Dorst, Pim Wilhelmus Maria, et al.
Publicado: (2022)

Leveraging the positives from the pandemic to strengthen infectious disease care in low-income and middle-income countries
por: Titanji, Boghuma K, et al.
Publicado: (2023)

Utilization Patterns and Projected Demand of Antiretroviral Drugs in Low- and Middle-Income Countries
por: Renaud-Théry, Françoise, et al.
Publicado: (2011)

HIV drug resistance surveillance in low- and middle-income countries: 2004 to 2010
por: Bertagnolio, S, et al.
Publicado: (2012)

Methodology to Forecast Volume and Cost of Cancer Drugs in Low- and Middle-Income Countries
por: Martei, Yehoda M., et al.
Publicado: (2018)

The safe handling of chemotherapy drugs in low- and middle-income countries: An overview of practices
por: von Grünigen, Sandrine, et al.
Publicado: (2021)

Drug shortages in low- and middle-income countries: Colombia as a case study
por: Sabogal De La Pava, Martha L., et al.
Publicado: (2022)

Evaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs
por: Miller, Jennifer E., et al.
Publicado: (2021)

Economic evaluations of interventions focusing on child abuse and neglect in high-income countries: a systematic review
por: Kugener, Tom, et al.
Publicado: (2023)

Phenomic technologies in drug discovery of neglected diseases
por: Nehrbass, Ulf
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_0b6js09oemoel8k16a2o4nisp2